VANCOUVER, BRITISH COLUMBIA--(Marketwire - Jan. 10, 2008) - Zecotek Photonics Inc. (TSX VENTURE:ZMS)(FRANKFURT:W1I) today announced that the Swiss-based Paul Scherrer Institute has selected Zecotek's proprietary Micro-pixel Avalanche Photo Diodes (MAPD) for trials in its next-generation Positron Emission Tomography (PET) medical imaging program. The Paul Scherrer Institute PET program is focused on advancing improvements in sensitivity, spatial resolution and image quality in PET scanners, based on the understanding that advances in PET are driven largely by progress in instrumentation, in particular the performance of scintillation materials, photo-detectors and read-out electronics. Higher resolution PET scanners will provide more detailed diagnoses, result in improved patient outcomes and broaden PET applications in brain function analysis and diagnosis.
